Page last updated: 2024-08-16

temozolomide and bay 11-7082

temozolomide has been researched along with bay 11-7082 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Akay, M; Akay, YM; Avci, NG; Ebrahimzadeh-Pustchi, S; Esquenazi, Y; Tandon, N; Zhu, JJ1
Akay, M; Akay, YM; Avci, NG; Pustchi, SE1

Other Studies

2 other study(ies) available for temozolomide and bay 11-7082

ArticleYear
NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.
    Scientific reports, 2020, 08-07, Volume: 10, Issue:1

    Topics: Actin Cytoskeleton; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Glioblastoma; Humans; Immunoblotting; NF-kappa B; Nitriles; Signal Transduction; Sulfones; Temozolomide; Transcription Factor RelA

2020
Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082.
    International journal of molecular sciences, 2020, Sep-28, Volume: 21, Issue:19

    Topics: Antineoplastic Agents, Alkylating; Astrocytes; Cell Line, Tumor; Cell Survival; Coculture Techniques; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Humans; Models, Biological; Neuroglia; Nitriles; Primary Cell Culture; Receptor, Notch1; Signal Transduction; Spheroids, Cellular; Sulfones; Survivin; Temozolomide; Tumor Microenvironment; Vimentin

2020